Description

Benign Prostate Hyperplasis (BPH) is prevalent among elderly men, influencing one third of those aged above 50. BPH is a benign histopathological disease characterized by hyperplasia of stromal and epithelial cells which results in enlarged prostate and then compressed urethra that makes urination difficult. BPH is treatable with medication and operation. Two main categories of drugs are α1-adrenergic receptor blocker and 5α-reductase inhibitor. The former one can effectively palliate symptoms through relaxing bladder neck and prostate and reducing urethral pressure, but it can’t cure BPH.

View Full Report at: http://www.marketresearchreports.biz/analysis/289082

Compared with other α1-adrenergic receptor blockers, tamsulosin hydrochloride developed by Yamanouchi enjoys higher selectivity and lower risk of urinary tract infections and therefore is fitter for BPH treatment. Ever since its debut in 1993 in Japan, tamsulosin hydrochloride has been sold in various brands in 64 countries according to Yamanouchi’s authorization to Boehringer Ingelheim.

Prostate drug market is highly concentrated in China. Three kinds of prostate drugs – finasteride, tamsulosin and prostat which occupy over 90% of prostate drug market altogether, reported over 10 million sales in sample hospitals in 2005. Tamsulosin develops rapidly after entering China with annual sales less than CNY 50 million in 2005 rising to CNY 201 million in 2014 and CAGR reaching 16.98% during this period. Tamsulosin enjoys a vast market demand in China and products made by Zhejiang Hailisheng Pharmaceutical Co., Ltd, Jiangsu Heng Rui Medicine Co., Ltd, Astellas Pharma Inc, Yamanouchi Pharmaceutical Co., Ltd and Kunming Jida Pharmaceutical Co., Ltd have taken up a large share of the market.

With the aging of the population in China, the incidence of BPH and its number of cases will keep going up. The market size of tamsulosin in China is expected to keep expanding in the next few years.

Download Detail Report With Complete TOC at: http://www.marketresearchreports.biz/sample/sample/289082



Readers can get at least the following information through this report:

market size of tamsulosin in China
major manufacturers of tamsulosin in Chinese market and their market share
retail price of tamsulosin in Chinese market
market outlook of tamsulosin in China

The author suggests the following groups of people purchase this report:

manufacturers of prostate drugs
investors/ research institutions interested in Chinese medicine market
any interest in Chinese medicine market, please contact CRI for customized survey service

Table of Content

1 Related Concepts of Tamsulosin
1.1 Indication
1.2 Sales Status in Global Market

2 Market Profile of Tamsulosin in China
2.1 Patent and Approval Status of Tamsulosin in China
2.2 Major Manufacturers
2.3 Sales Status of Tamsulosin in China

3 Survey on Sales Status of Tamsulosin in China, 2010-2014
3.1 Sales Value
3.1.1 Overall Sales Value
3.1.2 Sales Value by Regions
3.2 Sales Volume
3.2.1 Overall Sales Volume
3.2.2 Sales Volume by Regions


Browse all latest Articles of Market Research Reports
at:http://www.marketresearchreports.biz/articles


About us

MarketResearchReports.biz is the most comprehensive collection of market research reports.
MarketResearchReports.Biz services are specially designed to save time and money for our clients.
We are a one stop solution for all your research needs, our main offerings are syndicated research
reports, custom research, subscription access and consulting services. We serve all sizes and types
of companies spanning across various industries.

Browse Our Press Releases by Prnewswire:
http://www.prnewswire.com/news/marketresearchreports.biz

Browse More PressRelease:
http://www.prweb.com/search.aspx?search-releases=marketresearchreports.biz




Contact
Mr. Nachiket
90 Sate Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA: Canada Toll Free: 866-997-4948
Website: http://www.marketresearchreports.biz/
E: [email protected]